Trial Profile
Medication Facilitated Ureteral Access Sheath Deployment During Ureteroscopy and Endoscopic-Guided Percutaneous Nephrolithotomy: A Randomized Double-Blind Placebo Controlled Trial of Tadalafil, Tamsulosin and Combination
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Apr 2023
Price :
$35
*
At a glance
- Drugs Tadalafil (Primary) ; Tamsulosin (Primary)
- Indications Renal calculi; Urolithiasis
- Focus Therapeutic Use
- 15 Apr 2021 Planned End Date changed from 1 Jun 2019 to 1 Apr 2022.
- 15 Apr 2021 Planned primary completion date changed from 1 Jun 2019 to 1 Apr 2022.
- 29 Jul 2017 New trial record